<html>
	<head>
		<title>eurocapital <euro.o> seeks to market condoms</title>
		<meta name="keywords" content="places usa">
</head>
<body>
	<h3>eurocapital corp said its <europharmaceutical corp> affiliate has submitted four applications to the u.s. food and drug administration for approval to market in the u.s. three condom products to be made by <inkey sa> of barcelona.     the company said one is for approval to market a condom containing spermicide monoxynol-9, a second for the same condom without the spermicide and the third and fourth for marketing of a condom with a diffierent spermicide it did not identify that is said is effective in reducing the risk of sexual transmission of the aids virus.     the company said  the approval process on the last two applications may be lengthy.     it also said it has increased its ownership of europharmaceutical to 51 pct from 45 pct.     it said europharmaceutical's obligation to pay inkey for exclusive distribution rights to all inkey products has been cut to 500,000 dlrs from two mln dlrs and payment has been extended to 180 days after fda approval to market any of the condom products from 30 days.  it said europharmaceutical is now obligated to pay inkey two cts for each condom distributed and inkey will ship to europharmaceutical on open account.  reuter &#3;</h3>
</body>
</html>